All systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results – Authors' reply - KIVIRID

All systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results – Authors' reply

Authors: Hartmut Döhner, Axel Benner, Arnold Ganser

Published: 2023-08-29

DOI: 10.1016/s2352-3026(23)00242-9

Source: Full article

Abstract

No abstract found.